➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 005939

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 005939 describes BAL, which is a drug marketed by Akorn, B Braun, Avion Pharms, Solvay, Apotex Inc, Hikma, Mylan, Par Pharm Inc, Janssen Biotech, and Barr, and is included in twelve NDAs. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the BAL profile page.

The generic ingredient in BAL is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 005939
Formulation / Manufacturing:see details
Pharmacology for NDA: 005939
Mechanism of ActionMetal Chelating Activity
Medical Subject Heading (MeSH) Categories for 005939
Suppliers and Packaging for NDA: 005939
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BAL dimercaprol INJECTABLE;INJECTION 005939 NDA Akorn, Inc. 17478-526 17478-526-03 10 AMPULE in 1 CARTON (17478-526-03) > 3 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.